Level Biotechnology (3118) — Strategic Asset Allocation Index
Level Biotechnology (3118) has a Strategic Asset Allocation Index of 20.8% as of June 2023. Strategic assets (PP&E of NT$107.98 Million plus long-term investments of NT$-) total NT$107.98 Million, measured against net assets of NT$518.63 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Level Biotechnology balance sheet quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Level Biotechnology Strategic Asset Allocation Index (2017–2022)
This chart shows how Level Biotechnology's Strategic Asset Allocation Index has evolved across 6 annual periods from 2017 to 2022. As of June 2023, the index stands at 20.8%, representing strategic assets of NT$107.98 Million against net assets of NT$518.63 Million TWD. For live market cap and overall valuation, see 3118 market cap.
Annual Strategic Asset Allocation Index for Level Biotechnology (2017–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Level Biotechnology from 2017 to 2022, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See 3118 total equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (TWD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 20.8% | NT$113.01 Million | NT$113.01 Million | NT$- | NT$542.40 Million | ▼ -1.6 pp |
| 2021 | 22.5% | NT$122.41 Million | NT$122.41 Million | NT$- | NT$544.84 Million | ▼ -2.4 pp |
| 2020 | 24.9% | NT$131.75 Million | NT$131.75 Million | NT$- | NT$529.43 Million | ▼ -3.7 pp |
| 2019 | 28.6% | NT$146.74 Million | NT$146.74 Million | NT$- | NT$513.75 Million | ▲ +1.4 pp |
| 2018 | 27.1% | NT$135.32 Million | NT$135.32 Million | NT$- | NT$498.78 Million | ▼ -1.1 pp |
| 2017 | 28.2% | NT$147.27 Million | NT$147.27 Million | NT$- | NT$522.28 Million | — |